GTG at the moment appears to have minimal downside risk. By that I mean a complete re-rating downwards, not the day to day fluctuations. The license contracts should have put some sort of safety net under this stock. Impossible as it is for me to put a value on GTG at the moment the only downside risk I see would be a sudden halt in the licenses being granted. And that ain't gunna happen!
So, the risk / reward looks pretty attractive.
However, anything can and does happen!
Is there a better BioTech at the moment? I don't think there is.
Go you little ripper!!!!!!!!!!!!!
The downside risk
Add GTG (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.1¢ |
Change
-0.001(8.33%) |
Mkt cap ! $90.87M | |||
| Open | High | Low | Value | Volume |
| 1.2¢ | 1.2¢ | 1.0¢ | $321.7K | 29.29M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 62 | 40322852 | 1.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.1¢ | 6054529 | 8 |
View Market Depth
| Last trade - 16.11pm 25/01/2021 (20 minute delay) ? |
 (live)
|
|||||
|
Last
1.1¢ |
Change
-0.001 ( 5.41 %) |
||||
| Open | High | Low | Volume | ||
| 1.2¢ | 1.2¢ | 1.0¢ | 45491860 | ||
| Last updated 15.57pm 25/01/2021 (live) ? | |||||
| GTG (ASX) Chart |